DUBAI (Reuters) - Swiss drugmaker Roche Holding expects sales from its diagnostic division to grow faster in the United States than the market trend and it will not reduce prices despite reimbursement cuts in the U.S. health programme, an executive said.


from Reuters: Business News http://ift.tt/1p6Le8C
from Reuters: Business News http://ift.tt/1p6Le8C
Tidak ada komentar:
Posting Komentar